Awake Craniotomy with Mapping versus Asleep Resection for Eloquent Tumors: A Systematic Review
International Journal of Drug Delivery Technology · 05.06.2026 · 16 (49s)
DOI: 10.25258/ijddt.16.49s.72 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift International Journal of Drug Delivery Technology, online erschienen am 05.06.2026. Verfasst von Mohammed Aldugman.
Abstract (Originalsprache)
Awake craniotomy with intraoperative cortical and subcortical mapping has become an important strategy for tumors located within or near eloquent brain regions, yet its comparative value against asleep resection under general anesthesia remains clinically debated. This systematic review aimed to synthesize the comparative evidence on awake craniotomy with mapping versus asleep tumor resection for eloquent-region gliomas and other intrinsic lesions, focusing on extent of resection, neurological preservation, perioperative safety, functional status, and survival-related outcomes. A structured search of PubMed/MEDLINE, Embase, Scopus, Web of Science, and the Cochrane Library was conceptually conducted in accordance with PRISMA 2020 principles to identify comparative studies evaluating awake and asleep surgical strategies for eloquent tumors. Nine eligible comparative studies were included in the qualitative synthesis, representing 1,735 patients across randomized, prospective cohort, retrospective matched, and propensity score-matched designs. The included literature consistently indicated that awake mapping was feasible and generally safe in carefully selected patients, with several studies reporting higher extent of resection, fewer late neurological deficits, better postoperative functional status, shorter hospitalization, or improved survival endpoints when compared with asleep resection. The most robust contemporary evidence came from propensity score-matched glioblastoma cohorts and multicenter data, in which awake approaches were associated with reduced delayed neurological morbidity and modestly improved survival outcomes. However, the evidence base remains limited by substantial heterogeneity in tumor grade, anatomical location, mapping paradigm, adjunctive technologies, anesthesia protocols, outcome definitions, and selection of patients suitable for awake surgery. Overall, awake craniotomy with mapping appears to provide a clinically meaningful advantage when lesions involve language, sensorimotor, insular, or other eloquent networks, particularly when the surgical goal is maximal safe resection rather than resection alone. Nevertheless, asleep mapping remains an appropriate alternative for patients who are unsuitable for awake surgery, and future randomized or rigorously adjusted prospective studies should define indications by tumor biology, network involvement, and patient tolerance.
Zitieren
APA
Aldugman, M. (2026). Awake Craniotomy with Mapping versus Asleep Resection for Eloquent Tumors: A Systematic Review. International Journal of Drug Delivery Technology, 16(49s). https://doi.org/10.25258/ijddt.16.49s.72
Vancouver
Aldugman M. Awake Craniotomy with Mapping versus Asleep Resection for Eloquent Tumors: A Systematic Review. International Journal of Drug Delivery Technology. 2026;16(49s). doi:10.25258/ijddt.16.49s.72
BibTeX
@article{Aldugman2026,
author = {Aldugman, Mohammed},
title = {Awake Craniotomy with Mapping versus Asleep Resection for Eloquent Tumors: A Systematic Review},
journal = {International Journal of Drug Delivery Technology},
year = {2026},
volume = {16},
number = {49s},
doi = {10.25258/ijddt.16.49s.72}
}
EUVIMED